Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods.

Saved in:
Bibliographic Details
Title: Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods.
Authors: Ginex, Tiziana1 (AUTHOR) tiziana.ginex@cib.csic.es, Garaigorta, Urtzi2 (AUTHOR) ugaraigorta@cnb.csic.es, Ramírez, David3 (AUTHOR) david.ramirez@uautonoma.cl, Castro, Victoria2 (AUTHOR) vcastro@cnb.csic.es, Nozal, Vanesa1 (AUTHOR) vanesanozal@cib.csic.es, Maestro, Inés1 (AUTHOR) ines.maestro@cib.csic.es, García-Cárceles, Javier1 (AUTHOR) javier.garcia.carceles@cib.csic.es, Campillo, Nuria E.1 (AUTHOR) nuria.campillo@csic.es, Martinez, Ana1 (AUTHOR) ana.martinez@csic.es, Gastaminza, Pablo2 (AUTHOR) pgastaminza@cnb.csic.es, Gil, Carmen1 (AUTHOR) pgastaminza@cnb.csic.es
Source: Pharmaceuticals (14248247). Apr2021, Vol. 14 Issue 4, p332. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph14040332